# Rosalind Capital Partners

Investor in Toronto, Ontario, Canada

## About Rosalind Capital Partners

Rosalind Advisors, also known as Rosalind Capital, is a Toronto-based investment firm founded in 2006, operating as an event-driven equity hedge fund at the intersection of science and finance within the life sciences sector.

The firm manages several biotech-oriented funds, including Rosalind Capital Partners, Rosalind Master Fund, and Rosalind Offshore Fund, deploying long/short equity strategies to capitalize on consistent market inefficiencies and arbitrage opportunities within biotech public markets.

Its sector focus centers on biotechnology and life sciences, spanning oncology, ophthalmology, and dermatology. Notable holdings and investments include Delcath Systems, Savara, Fennec Pharmaceuticals, Replimune Group, ArriVent BioPharma, Biofrontera, and Kiora Pharmaceuticals.

Rosalind's investment approach favors concentrated positions in public biotech securities backed by deep scientific and clinical understanding, rather than broad diversification. Its criteria favor companies demonstrating strong growth potential and innovation, primarily across North American markets.

## People

- **Steven Salamon**, Co-Founder, President & CEO

## Key Facts

- **Location:** Toronto, Ontario
- **Country:** Canada
- **Investor Type:** Venture Capital
- **Founded:** 2006

## Investment Industries

- Biotech
- Medical/Healthcare

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/rosalind-capital-partners
- More investors: [Biotech Investors in Ontario](https://askforfunding.com/site/angel-investors/ontario/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.